1Samuel D,Muller R,Alexanden G,et al.Liver transplantation in european patients with hepatitis B surface antigen.New Engl J Med,1993,329(25):1842-1848.
3Samuel D,Feray C,Bismuth H.Hepatitis virus and liver transplantation.J Gastroenterol Hepatol,1997,12(suppl):335-342.
4Lanford RE,Michals MG,Chavez D,et al.Persistence of extrahepatic Hepatitis B virus DNA in the absence of detectable hepatic replication in patient witht baboon liver transplants.J Med Virol,1995,46(3):207-212.
5Feray C,Zignego AL,Samuel D,et al.Persistent hepatitis B virus infection of mononuclear blood cells without concomitant liver infection.The liver transplantation mode.Transplantation.1990,49(6):1155-1158.
6Gonzalez RA,De La MM,DE La TJ,et al.Levels of HBV DNA and HBsAg after acute liver allograft rejection treatment by corticoids and OKT3.Clin Transplant,2000,14(3):208-211.
9Markiwitz J,Pakrasi A,Hollis P,et al.Efficacy of lamivdine for prophylaxis and treatment of hepatitis B in liver transplantation patients.Hepatology,1996,24(1):188-193.
二级参考文献17
1Ishitani M. HBV vaccination and liver transplantation for hepatitis B: winning by recruiting from within? Liver Transpl, 2000, 6: 659-661.
2BenAri Z, Shmueli D, Shapira Z, et al. Loss of serum HBsAg after interferon-α therapy in liver transplant patients with recurrent hepatitis-B infection. Liver Transpl Surg, 1997, 3: 394-397.
3Markowitz JS, Martin P, Conrad AJ, et al. Proplylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin. Hepatitis, 1998, 28: 585-589.
4Nery JR, Weppler D, Rodriguez M, et al. Efficacy of lamivudine in controlling hepatitis B virus recurrence after liver transplantation. Transplantation, 1998, 65: 1615-1621.
5Singh N, Gayowski T, Wannstedt CF, et al. Pretransplant famciclovir as Prophylaxis for hepatitis B virus recurrence after liver transplantation. Transplantation, 1997, 63: 1415-1419.
6Perrillo R, Rakela J, Dienstag J, et al. Multicenter study of lamivudine therapy for hepatitis B after liver trans-plantation. Hepatology, 1999, 29: 1581-1586.
8Feray C, Caccamo L, Alexander GJ, et al. European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. Gastroenterology, 1999, 117: 619-625.
9Mutimer D, Pillay D, Dragon E, et al. High pre-treatment serum hepatitis B virus titer predicts failure of lamivudine prophylaxis and graft re-infection after liver transplantation. J Hepatpol, 1999, 30: 715-721.
10Segovia R, SanchezFueyo A, Rimola A, et al. Evidence of serious graft damage induced by de novo hepatitis B virus infection after liver transplantation. Liver Transpl, 2001, 7:106-112.
